Phaeno Therapeutics

Phaeno Therapeutics is a biotechnology company specializing in functional precision medicine and phenotypic drug discovery. The company utilizes its proprietary Phaeno-Screen platform, which combines advanced cell biology, high-content imaging, and machine learning to identify small molecules that reverse disease phenotypes. Their primary focus areas include oncology and inflammatory diseases, with a specific emphasis on modulating the Pregnane X receptor (PXR) for gastrointestinal health. By focusing on the functional outcomes of drug candidates in patient-derived models, Phaeno aims to develop more effective therapies for complex and undruggable conditions. The company's approach integrates deep biological insights with computational analysis to accelerate the discovery of novel therapeutic leads.